The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Effect of Intranasal Insulin on Cognitive Function: A Systematic Review
Abstract
AIM: Epidemiological and mechanistic studies raised the possibility that cognitive function may be affected by brain responses to insulin. We systematically reviewed and analyzed existing clinical trials that assessed the potential beneficial effects of intranasal insulin administration on cognitive functions. METHODS: Interventional studies measuring changes in cognitive functions in response to intranasal insulin were retrieved and included if they were in English and assessed cognitive functions before and after treatment. Cohen's effect size was calculated to allow comparison between studies. RESULTS: Eight studies (328 participants) were analyzed. No significant side effects of intranasal insulin administration were reported. Seven studies included healthy subjects' response to intranasal insulin, and three evaluated the cognitive effect among patients with minimal cognitive impairment or overt Alzheimer's disease. In healthy people, Cohen's effect size calculations suggest that only 160 IU/d intranasal insulin induced potential beneficial effects. Although females, when compared head-to-head, exhibited greater improvements in cognitive tests than men, the composite analysis of all included studies did not support this trend. Among cognitively impaired patients, only lower doses of insulin were assessed, and 20 IU revealed potential beneficial effects on cognitive functions. This was significant in a single study assessing long-term intranasal insulin administration, whereas acute administration of 20 IU intranasal insulin tended to show a beneficial effect on immediate recall in Apo ε4(-), but not Apo ε4(+), patients. CONCLUSIONS: The current limited clinical experience suggests potential beneficial cognitive effects of intranasal insulin. Analyses provide clinical considerations for future research aimed at elucidating whether intranasal insulin may be used to improve cognitive functions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Results obtained from preclinical studies and controlled trials on healthy volunteers and individuals with mild cognitive impairment or Alzheimer’s disease have supported the potential of intranasal insulin in improving memory performance [113].”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [113]
Citations
Cites
Health Measurement Scales: A Practical Guide to Their Development and Use
Streiner, D. L., Norman, G. R., & Cairney, J. (1989) · Cited by 9,595
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
Gauthier, S. G., Reisberg, ., Zaudig, M., Petersen, R. C., Ritchie, K. A., Broich, K., Belleville, S., Brodaty, H., Bennett, D. A., Chertkow, H. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 4,094
Effect size, confidence interval and statistical significance: a practical guide for biologists
Nakagawa, S., & Cuthill, I. C. (2007) · Biological Reviews · doi:10.1111/j.1469-185x.2007.00027.x · Cited by 3,835
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Mild Cognitive Impairment: Ten Years Later
Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Smith, G. E., & Jack, C. R. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.266 · Cited by 1,447
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–159 of 159
Luckhoff, H. K., Kilian, S., Olivier, M. R., Phahladira, L., Scheffler, F., du Plessis, S., Chiliza, B., Asmal, L., & Emsley, R. A. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-018-0372-6 · Cited by 9
Novel Therapeutic Targets for Major Depressive Disorder
Lazar, M. A., & McIntyre, R. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00034-2 · Cited by 9
Diabetes-Related Cognitive Decline, a Global Health Issue, and New Treatments Approaches
Novak, V., Gómez, F., Dias, A. C., Maldonado, D. P., & Alfaro, F. J. (2017) · International Journal of Privacy and Health Information Management · doi:10.4018/ijphim.2017070104 · Cited by 8
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_10 · Cited by 9
Zhang, Y., Chang-Quan, H., Li, Y., & Bi-Rong, D. (2013) · AGE · doi:10.1007/s11357-013-9547-6 · Cited by 7
Toward the Decipherment of Molecular Interactions in the Diabetic Brain
Chomová, M. (2022) · Biomedicines · doi:10.3390/biomedicines10010115 · Cited by 8
Geary, D. C. (2020) · Journal of Intelligence · doi:10.3390/jintelligence8040042 · Cited by 7
Pragmatic function impairment and Alzheimer’s dementia
Schatz, S., & González-Rivera, M. (2016) · Pragmatics & Cognition · doi:10.1075/pc.23.2.07sch · Cited by 5
Gómez‐Guijarro, M. D., Cavero‐Redondo, I., Saz‐Lara, A., Pascual‐Morena, C., Álvarez-Bueno, C., & Martínez‐García, I. (2024) · Cognitive Neurodynamics · doi:10.1007/s11571-024-10138-5 · Cited by 5
Gümüşkaya, P. Ö., Altun, Ö., Yıldırım, E., Yüztaş, N. K., Özsoy, N., Kalyon, S., İrak, L., Özcan, M., Altun, Z. Ö., Demir, P., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103460 · Cited by 6
Fatke, B., Förstl, H., & Risse, A. (2013) · Der Diabetologe · doi:10.1007/s11428-013-1109-0 · Cited by 4
Śmierciak, N., Krzyściak, W., Szwajca, M., Bryll, A., Popiela, T. J., Karcz, P., & Pilecki, M. W. (2021) · Psychiatria Polska · doi:10.12740/pp/119021 · Cited by 5
Chintamaneni, P. K., Pindiprolu, S. K. S. S., Krishnamurthy, P. T., & Varshini, M. S. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_12 · Cited by 3
Tadevosyan, N. E., Khachunts, A. S., Gohargani, M., Sahakyan, A. A., & Tumanian, A. A. (2022) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093022020247 · Cited by 3
Therapeutics of Alzheimer’s Disease
Herrera-Rivero, M., & Emiliano, G. (2011) · InTech eBooks · doi:10.5772/27990 · Cited by 3
Zhang, L., Song, J.-L., Qiu, L.-Q., Li, Q., Yu, X., Lu, B., & Chen, G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1670982 · Cited by 2
Das, S. K., Bashir, B., Kolekar, K. A., Harish, V., Patle, D., Vishwas, S., Mittal, N., Jha, S. K., Kumar, P., Gupta, G. K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.103000 · Cited by 2
Drug repurposing for disease-modifying effects in multiple system atrophy
Jeong, S. H., Shin, J. Y., & Lee, P. H. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00551-7 · Cited by 2
Patel, D. A., Patel, D. J., & Kantharia, N. D. (2018) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20183021 · Cited by 2
Diabetes-Related Cognitive Decline, a Global Health Issue, and New Treatment Approaches
Novak, V., Gómez, F., Dias, A. C., Maldonado, D. P., & Alfaro, F. J. (2018) · IGI Global eBooks · doi:10.4018/978-1-5225-5484-4.ch039 · Cited by 2
The Link Between Obesity and Depression: Exploring Shared Mechanisms
Woo, Y. S., & Bahk, W. (2017) · Springer eBooks · doi:10.1007/978-981-10-6577-4_15 · Cited by 2
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neuman, S. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-1 · Cited by 2
Molecular diagnosis of autism spectrum disorder through whole exome sequencing
de Almeida, T. F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2019.tde-04022019-092804 · Cited by 2
Ojha, A., Vidwans, H., & Watve, M. (2022) · medRxiv · doi:10.1101/2022.08.02.22278347 · Cited by 2
Ojha, A., & Watve, M. (2024) · Qeios · doi:10.32388/gl52db · Cited by 4
Assessment of Cognitive Functions in Elderly Patients with Type 2 Diabetes Mellitus
Akhmedova, A. A., Омариевна, У. Ф., & Demidova, T. Y. (2025) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-025-01862-4 · Cited by 1
Goodson, M. M., Gwizdala, K. L., Manrique, I., Rao, A., Beyl, R. A., Martin, C. K., Firmin, S., Salceanu, V., Newton, R. L., & Carmichael, O. T. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf138 · Cited by 1
Bakrey, H., Abdelaziz, M. A. A., Magbool, F. F., Bakrey, A., Omer, O. I. A., Abdelrahim, I., & Abdu, A. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03285-3 · Cited by 1
Ng, K. T., Lim, W. E., Teoh, W. Y., & Abidin, M. F. Z. (2026) · Indian Journal of Anaesthesia · doi:10.4103/ija.ija_728_25 · Cited by 1
Fatke, B., & Förstl, H. (2013) · Der Diabetologe · doi:10.1007/s11428-012-0951-9 · Cited by 2
Intranasal insulin: is there a promise for treatment of diabetes-related cognitive decline?
Novak, V. (2014) · Diabetes Management · doi:10.2217/dmt.14.12 · Cited by 1
The Altered Cerebral Homeostasis with Aging in Diabetes Mellitus and Cognitive Decline
Nikhra, V. (2018) · Gerontology & Geriatrics Studies · doi:10.31031/ggs.2018.03.000556 · Cited by 1
Contemporary approaches to correction of cognitive impairment in endogenous depression
Oleichik, I. V., Shishkovskaia, T. I., & Баранов, П. А. (2020) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2020-4-82-93 · Cited by 1
Fessel, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093151 · Cited by 1
Cukierman‐Yaffe, T., Ramasundarahettige, C. F., Bosch, J., & Gerstein, H. C. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15412 · Cited by 1
Self-citationIncreased Brain Glutathione Levels by Intranasal Insulin Administration
Kawashima, T., Bhadhprasit, W., Matsumura, N., Kinoshita, C., & Aoyama, K. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040284 · Cited by 1
The Relationship Between Diabetes and Alzheimer's Disease
Kazkayası, İ., BOZKURT, N. B., & Uma, S. (2018) · Journal of Literature Pharmacy Sciences · doi:10.5336/pharmsci.2017-58894 · Cited by 1
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_10 · Cited by 1
Ojha, A., Vidwans, H., & Watve, M. (2023) · Qeios · doi:10.32388/ih7kep · Cited by 1
Cukierman‐Yaffe, T. (2013) · Diabetes Management · doi:10.2217/dmt.13.60
Self-citationKievit, P., & Purnell, J. Q. (2012) · Diabetes · doi:10.2337/db12-0642
Effects of insulin gene dosage on body weight and glucose homeostasis
Mehran, A. E. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0167270
Maher, P. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-28995-3_8
CognitiveFunctionandtheRiskfor Diabetes Among Young Men
Twig, G., Gluzman, I., Tirosh, A., Gerstein, H. C., Yaniv, G., Afek, A. B., Derazne, E., Tzur, D., Karasik, A., Gordon, B., et al. (2014)
Self-citationШипилов, В. Н., Trost, A. M., Chistyakova, O. V., Derkach, K. V., & Shpakov, A. O. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0428-9
Wang, Y. (2014) · TSpace (University of Toronto)
Fatke, B., Förstl, H., & Risse, A. (2013) · Humanmedizin kompakt · doi:10.1007/s40355-013-0018-1
Novel therapeutic drug targets for bipolar disorder
Rosenblat, J. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00037-5
Ojha, A., & Watve, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.19.477014
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-3
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neumann, S. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-2
Ткачук, О. В., Тkachuk, S. S., Povar, M. A., Kysylytsia, S. O., Sоrokhan, V. D., Denysenko, O. I., & Perepeliuk, M. D. (2022) · Clinical & experimental pathology · doi:10.24061/1727-4338.xxi.2.80.2022.10
Towairqi, H. A., Alshanqiti, A., Alsaadi, R., & Alhindi, Y. Z. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs221651355
Intranasal insulin therapy in the treatment of alzheimer’s disease – A narrative review
Nene, A., & Santoni, J. R. (2023) · IP Indian Journal of Anatomy and Surgery of Head Neck and Brain · doi:10.18231/j.ijashnb.2023.006
Cognitive functions assessment of elderly patients with type 2 diabetes mellitus
Akhmedova, A. A., Омариевна, У. Ф., & Demidova, T. Y. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512503146
Chakraborty, S., & Pal, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00023-2
Lin, C.-H., Hung, P., Chung, M., Wu, L.-Y., & Chung, C. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100645
Woo, Y. S., & Kwon, Y. (2026) · Springer eBooks · doi:10.1007/978-981-92-1331-3_10
Metadata
- Authors
- Shemesh, E., Rudich, A., Harman-Boehm, I., & Cukierman-Yaffe, T.
- Affiliations
- Ben-Gurion University of the Negev (IL)
- Corresponding author
- Rudich, Assaf
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-02
- Volume
- 97
- Issue
- 2
- Pages
- 366-376
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2112186260
- Cited by
- 162
- References
- 54
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 6 · 2023: 6 · 2022: 12 · 2021: 8 · 2020: 12 · 2019: 11 · 2018: 9 · 2017: 7 · 2016: 17 · 2015: 11 · 2014: 23 · 2013: 18 · 2012: 8
- FWCI
- 10.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- intranasal insulin, cognitive function, Alzheimer's disease, cognitive impairment, sex differences, APOE ε4, immediate recall, insulin dose, brain insulin signaling
- MeSH terms
- Administration, Intranasal, Alzheimer Disease, Cognition, Cognition Disorders, Dose-Response Relationship, Drug, Female, Humans, Insulin, Male, Sex Characteristics, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
